New gout drug HEC93077 enters early human testing
NCT ID NCT05127772
First seen May 14, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This early-stage trial tested a new medicine called HEC93077 in 126 healthy Chinese volunteers and people with high uric acid (gout). The main goals were to check safety, how the drug moves through the body, and how it affects uric acid levels. Participants received either the drug or a placebo, and researchers measured side effects and drug levels in blood and urine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Universicity Care of Luzhong Hospital
Zibo, Shandong, 255400, China
Conditions
Explore the condition pages connected to this study.